HR 1526
118th Congress
House
Health
Cancer
Genetics
Health care coverage and access
Health promotion and preventive care
Hereditary and development disorders
Medical tests and diagnostic methods
Medicare
Reducing Hereditary Cancer Act
Introduced: March 9, 2023
Introduced by:
Wasserman Schultz, Debbie
Democratic
· Florida
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Mar 17, 2023
Referred to the Subcommittee on Health.
Mar 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 9, 2023
Introduced in House
Plain-English summary
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4